Up Next
-
2m 18sPart 2 | Session 9 EuroPCR 22: SYNERGY™ Non-inferior to BioMatrix NeoFlex in OCT SORT-OUT VIII
-
5m 9s
-
7m 18sPart 2 | Session 11 EuroPCR 22: Balloon Vs Self-Expanding Valves in Valve-in-Valve TAVI
-
5m 52sPart 2 | Session 12 EuroPCR 22: MitraClip in Atrial Functional Mitral Regurgitation
-
2m 15sPart 2 | Session 13 EuroPCR 22: SCB with Micro-Reservoir Technology in Coronary Lesions
-
4m 46sPart 2 | Session 14 EuroPCR 22: FORWARD PRO Study Shows No Durability Issues After 3 Years
-
4m 25sPart 2 | Session 15 EuroPCR 22: DEB & DES in the Treatment of Diffuse CAD
-
3m 16sPart 2 | Session 16 EuroPCR 22: EASTBOURNE Registry indicates Satefy of Sirolimus-Coated Balloon
-
4m 27sPart 2 | Session 17 EuroPCR 22: JenaValve TAVR System for the Treatment of Aortic Regurgitation
-
7m 7sPart 2 | Session 18 EuroPCR 22: Transcatheter Tricuspid Valve Repair with PASCAL System
-
6m 53s
-
20m 24sPart 1 | Session 1 EuroPCR 22 Late-breaking Science Preview
-
27m 14sPart 1 | Session 2 EuroPCR 22 Late-breaking Science Wrap-Up
-
3m 28sPart 2 | Session 1 EuroPCR 22: AQVA Study Shows Superiority in QFR-Based Virtual PCI Arm
-
5m 10s
-
7m 50s
-
5m 56s
-
3m 34sPart 2 | Session 5 EuroPCR 22: CRUZ-HBR Indicates Use Of Supraflux™ Cruz Stent Is Favourable
-
4m 49s
-
3m 53sPart 2 | Session 7 EuroPCR 22: Short-Term Clinical Outcomes of ACURATE neo2™
Overview
Our regular review series View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) provide a concise analysis of the late-breaking science trials and spotlight questions that could change treatment strategies in interventional cardiology.
Short, accessible Expert Interviews will be available with select faculty focusing on the results, applicability, and impact on future research.
More from this programme
Part 1
View from the Thoraxcenter
Part 2